Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
about
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in YouthsComparing the efficacy of medications for ADHD using meta-analysisEfficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adultsWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.Syncope associated with concurrent amitriptyline and fluconazole therapy.Absence of effect of stimulants on the phamacokinetics of desipramine in children.Electrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.Pharmacologic treatment of eating disorders.Health effects of energy drinks on children, adolescents, and young adults.Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.A drug utilisation study of antidepressants in children and adolescents using the General Practice Research DatabaseThe psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.Electrophysiological changes of cardiac function during antidepressant treatment.Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.Background, clinical features and treatment of attention deficit hyperactivity disorder in children.Attention Deficit Hyperactivity Disorder (ADHD): Selected review of causes, comorbidity and treatment.Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.Association Between Depression, Anxiety, and Antidepressant Use With T-Wave Amplitude and QT-Interval.
P2860
Q24642024-6B6A23D1-2A5F-4899-A4DB-1917BC9F2ADDQ24685027-BB2E200E-9DDC-4E5E-A47B-3C96AECC82B9Q28246506-64734ABA-4AE1-432A-ABC3-4EC71A6754D1Q31121208-AE5AF3DC-999A-42CE-9F0B-6EE66DC8C826Q31805805-F2194F56-C709-464E-A743-E2A7D0B74AD6Q33677560-499A23B6-5048-45A0-800B-1AA2F4094A58Q34093866-B1885064-564D-4664-8F02-D28E8C6C5E75Q34578945-6B7E4239-CC1D-476A-9149-35EFFB3750D5Q34622073-2CFD1438-F5F8-488C-A9CF-8426AF8DF6BEQ34622573-0F990071-85E0-4604-8CCB-C5FAD750E1A4Q34726274-B7CF82B2-61A8-4168-8855-A6EA8E23500EQ35169643-7912FD6E-596A-4CF9-95D3-97964566D44EQ35277907-A61B16C6-1D61-4AB4-82CF-BB8B8365D1F4Q36068453-D5110FC5-9622-4EB6-891B-B51C787FABFCQ37362668-1DCBA6C0-A939-42FC-8DAF-659D5B1882C5Q38060572-A4460AF3-5BEF-4A6D-8D81-6B9933126C35Q38122410-D3170E6C-22DB-4094-A60A-BB5BDB20C475Q38221613-D6C16882-9A8B-4738-A2D1-09FD63CF5589Q48326651-89926C8C-E7A2-4D93-BFDC-59A834F57B0BQ55341280-46E6AF17-DC7F-4A7C-886D-74C9D82CE50A
P2860
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cardiovascular effects of ther ...... s in children and adolescents.
@en
type
label
Cardiovascular effects of ther ...... s in children and adolescents.
@en
prefLabel
Cardiovascular effects of ther ...... s in children and adolescents.
@en
P2093
P1476
Cardiovascular effects of ther ...... s in children and adolescents.
@en
P2093
Baldessarini RJ
Biederman J
Birmaher B
Goldblatt A
Schleifer D
Spencer TJ
P304
P356
10.1097/00004583-199611000-00018
P577
1996-11-01T00:00:00Z